ISSN: 2149-2247 | E-ISSN: 2149-2549
Erciyes Medical Journal Full Recovery of a Child with Fulminant Myocarditis after Levosimendan Therapy [Erciyes Med J]
Erciyes Med J. 2021; 43(5): 505-507 | DOI: 10.14744/etd.2020.87513

Full Recovery of a Child with Fulminant Myocarditis after Levosimendan Therapy

Mustafa Argun1, Işın Sönmez2, Hasan Samsa2, Onur Yilmaz2, Mustafa Yılmaz3
1Department of Pediatric Cardiology, Health Sciences University Faculty of Medicine, Kayseri City Training and Research Hospital, Kayseri, Turkey
2Department of Pediatrics, Health Sciences University Faculty of Medicine, Kayseri City Training and Research Hospital, Kayseri, Turkey
3Department of Pediatric Cardiovascular Surgery, Health Sciences University Faculty of Medicine, Kayseri City Training and Research Hospital, Kayseri, Turkey

Background: Fulminant myocarditis is a rare, life-threatening condition. Decompensated heart failure caused by fulminant myocarditis is managed with inotropic agents, mechanical ventilation, and mechanical circulatory support. Levosimendan is a novel inotropic agent that also has vasodilatory and cardioprotective properties. However, information about levosimendan use in children is limited in the literature.
Case Report: We report the full recovery of a 3.5-year-old male patient with an inotrope-resistant heart failure treated with levosimendan therapy who was diagnosed as having fulminant myocarditis after presenting with acute decompensated heart failure and low cardiac output.
Conclusion: Levosimendan therapy may offer an effective treatment for children with acute decompensated heart failure secondary to fulminant myocarditis resistant to standard therapy.

Keywords: Fulminant myocarditis, levosimendan, child.

Mustafa Argun, Işın Sönmez, Hasan Samsa, Onur Yilmaz, Mustafa Yılmaz. Full Recovery of a Child with Fulminant Myocarditis after Levosimendan Therapy. Erciyes Med J. 2021; 43(5): 505-507

Corresponding Author: Mustafa Argun, Türkiye
LookUs & Online Makale